Shaanxi BLOOM Tech Co., Ltd. is one of the most experienced manufacturers and suppliers of enalapril maleate 2.5 in China. Welcome to wholesale bulk high quality enalapril maleate 2.5 for sale here from our factory. Good service and reasonable price are available.
Enalapril Maleate 2.5 (Enalapril Maleate-2.5mg tablets) is a typical representative of angiotensin-converting enzyme inhibitors (ACEIs), and its active ingredient is enalapril maleate. This drug exerts its antihypertensive and cardioprotective effects by inhibiting angiotensin-converting enzyme (ACE) and blocking the conversion of angiotensin I to angiotensin II.
The formulation is in the form of white or off white circular biconvex tablets, with a volume of 2.5mg tablets smaller than 5mg tablets for easy dosage adjustment. After oral administration, enalapril is rapidly absorbed in the gastrointestinal tract and hydrolyzed into the active metabolite enalapril in the liver.
 |
 |
Enalapril Maleate COA
The half-life of enalapril is about 11 hours, and stable blood drug concentration can be maintained by administering 1-2 times a day. Food can delay absorption but does not affect total bioavailability, so patients can choose to take it before or after meals according to their habits. Medications are mainly excreted through the kidneys, and patients with renal insufficiency need to adjust the dosage to avoid accumulation of toxicity. ACE not only participates in the generation of angiotensin II, but also is responsible for the degradation of bradykinin. Enalapril inhibits ACE and reduces the degradation of bradykinin, leading to its accumulation in local tissues. Bradykinin exerts vasodilation and antiplatelet aggregation effects by stimulating the release of nitric oxide (NO) and prostaglandins (PG). This mechanism may explain the additional benefits of enalapril in improving endothelial function and preventing cardiovascular events.
The production process of Enalapril Maleate 2.5 mainly includes three core steps: raw material synthesis, formulation process, and quality control. The specific process is as follows:
API synthesis
The synthesis of Enalapril Maleate involves multiple chemical reactions, with the core steps being:
Intermediate preparation: Using L-proline and N - [(S) -1-ethoxycarbonyl-3-phenylpropyl] - L-alanine as raw materials, enalapril silyl ester is generated through condensation reaction. This step requires strict control of the reaction temperature (such as 0 ℃ to room temperature) and solvent selection (such as tetrahydrofuran) to ensure the purity and yield of the intermediate.
Hydrolysis reaction: Enalapril silicon ester is hydrolyzed under acidic conditions to remove protective groups and generate enalapril. The hydrolysis conditions (such as pH value and temperature) have a significant impact on the quality of the product, and the optimal parameters need to be determined through experimental optimization.
Salt formation reaction: Enalapril reacts with maleic acid in organic solvents such as ethyl acetate to produce enalapril maleate. This step requires controlling the reaction time and temperature to avoid the generation of by-products.
Preparation process
The preparation process of Enalapril Maleate 2.5 tablets mainly includes two methods: wet granulation and direct compression. Among them, wet granulation is more commonly used:
Wet granulation:
- Mixing: Sift and mix the excipients such as enalapril maleate, microcrystalline cellulose, L-hydroxypropyl cellulose, starch, etc. evenly.
- Granulation: Add 50% ethanol to make suitable soft materials, sieve and pelletize. This step requires controlling the humidity and particle size of the soft material to ensure the flowability and compressibility of the particles.
- Drying: Dry the particles under ventilated conditions at 40 ℃ to remove moisture. During the drying process, it is necessary to regularly flip the particles to avoid clumping.
- Total mixing: Add magnesium stearate and talc powder and mix evenly to improve the demolding and flowability of the tablets.
- Tablet pressing: Press the mixed particles into tablets. During the tablet pressing process, pressure and tablet weight need to be controlled to ensure the hardness and uniformity of the tablet content.
- Direct compression: Some processes use direct compression technology, which involves mixing raw materials and excipients directly before compression. This method simplifies the production process, but it is necessary to ensure good fluidity of the raw materials and excipients to avoid problems such as cracking and sticking during the tablet pressing process.
Quality control
To ensure the stable quality of Enalapril Maleate 2.5 tablets, strict quality control is required:
Content determination
High performance liquid chromatography (HPLC) was used to determine the content of enalapril maleate in tablets. The detection wavelength is usually 215nm, ensuring that the content is between 90.0% and 110.0% of the labeled amount.
Dissolution test
Using water as the dissolution medium, with a speed of 100 revolutions per minute, the dissolution amount should not be less than 75% of the labeled amount after 30 minutes. Dissolution is an important indicator for evaluating tablet quality and requires regular testing.
Regarding substance inspection
The impurity peak area is detected by HPLC to ensure that the total impurities do not exceed the main peak area of the control solution. The control of substances is crucial for ensuring the safety and effectiveness of tablets.
Other inspections
Including the appearance, hardness, brittleness, weight differences, etc. of the tablets. These inspection items need to comply with relevant pharmacopoeia standards to ensure the stability of tablet quality.
Biological impact on the environment
Enalapril Maleate 2.5 can cause significant harm to ecosystems in conventional use or environmental emissions, but its residues as a drug in the environment may have potential indirect effects on microbial communities and food chains through bioaccumulation or transmission of resistance genes. The following analysis is conducted from the perspectives of drug environmental behavior, ecological toxicity, degradation pathways, and risk prevention and control:
Emission pathway
Enalapril Maleate mainly enters the municipal sewage system through patient excretion (urine/feces), and some drug residues that have not been completely removed by the sewage treatment plant may be discharged into surface water bodies with the effluent. In addition, the disposal of expired drugs and the discharge of pharmaceutical wastewater are also potential sources of pollution.
environmental stability
This drug is an angiotensin-converting enzyme inhibitor (ACEI) with a stable chemical structure and a long half-life (several days to weeks) in natural water bodies. It is easily adsorbed on sediments and exists for a long time.
Bioaccumulation
Although there is no clear evidence of significant accumulation in higher organisms, long-term exposure to low concentrations may affect benthic organisms or aquatic insects through food chain transmission.
Enalapril Maleate acts on aquatic ecosystems
Acute toxicity
Existing studies have shown that Enalapril Maleate has low acute toxicity to fish (such as zebrafish) and aquatic invertebrates (such as Daphnia) (LC50/EC50>10mg/L), which is much higher than the actual detected concentration in the environment (ng/L - μ g/L level).
Chronic effects
Endocrine disruption: As an ACEI, it may interfere with the renin-angiotensin system (RAS) of aquatic organisms, affecting osmotic regulation, reproductive behavior, or embryonic development.
Microbial community changes
Long term low-dose exposure may inhibit sensitive microbial populations, leading to a decrease in water self purification capacity or the proliferation of drug-resistant strains.Resistance gene transmission: Residual drugs in sewage treatment plants may induce bacteria to produce resistance genes, which can spread to environmental microorganisms through horizontal gene transfer.
synergy
When coexisting with other drugs such as antibiotics and anti-inflammatory drugs, it may increase the pressure on the ecosystem through joint toxicity.
Enalapril Maleate strikes impact on terrestrial ecosystems
Soil pollution
Drug residues entering the soil through sewage irrigation or agricultural sludge may affect soil microbial activity (such as nitrogen cycling related bacterial communities), reduce soil fertility, or promote the colonization of drug-resistant bacteria.
Plant absorption
Low concentration drugs may be absorbed by plant roots and transmitted to herbivorous animals through the food chain, but there is currently no clear evidence to suggest that they pose a threat to plant growth or human food safety.
Wildlife exposure
In areas where drinking water sources are contaminated, wild animals may be exposed to drugs through drinking water or ingestion of contaminated organisms, which can have long-term effects on their physiological functions (such as blood pressure regulation).
What can Enalapril Maleate do for the environment
Risk assessment
At current environmental concentrations, Enalapril Maleate has a low direct acute risk to non target organisms, but attention should be paid to its long-term cumulative effects as a "pseudo persistent pollutant" and the risk of resistance gene transmission.
Prevention and control measures
Source control: Optimize pharmaceutical processes and reduce production wastewater discharge; Promote drug recycling programs to avoid indiscriminate disposal.
Wastewater treatment upgrade
Advanced oxidation technologies such as ozone and photocatalysis or membrane bioreactor (MBR) are used to improve drug removal efficiency.
Environmental monitoring
Establish a long-term monitoring network for drug residues in water and soil, and assess ecological risk thresholds.
Alternative research and development: Developing environmentally friendly drugs or biodegradable agents to reduce persistent chemical emissions.
Current and future directions
Research gap
Lack of long-term research on drug migration and transformation in complex environmental media such as biofilms and sediments.
Insufficient understanding of the ecological effects of mixed drug exposure.
The transmission mechanism and ecological consequences of drug resistance genes in the environment need further clarification.
Future focus
Conduct research on multi-media environmental models to predict the long-term cumulative effects of drugs.
Evaluate the impact of drug residues on microbial community function, such as carbon/nitrogen cycling.
Explore the correlation between drug environmental risks and human health risks.
FAQ
What is the difference between enalapril and enalapril maleate?
Enalapril is the ethyl ester of enalaprilat. It has little pharmacological activity until it is hydrolyzed in the liver to enalaprilat. Enalapril is available commercially as the maleate salt. Enalapril maleate is absorbed better from the gastrointestinal tract in dogs than enalaprilat.
What is enalapril maleate?
Enalapril maleate is a prominent angiotensin-converting enzyme inhibitor approved by the US Food and Drug Administration (FDA) for the treatment of heart failure, chronic hypertension, and asymptomatic left ventricular dysfunction. The FDA has approved a fixed-dose combination of enalapril with hydrochlorothiazide.
Hot Tags: enalapril maleate 2.5, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale